Jump to content

Nita Madhav

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 03:32, 2 March 2023 (Alter: template type. Add: magazine. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 501/1968). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Nita Madhav is an epidemiologist and risk modeler who was CEO of Metabiota from 2019 - 2022.[1][2]

Education

Madhav graduated from Yale University in 2002 with degrees in ecology and evolutionary biology, and received her Master's in Public health from Emory University in 2005.[3]

Career

After time at the Centers for Disease Control and Prevention and AIR Worldwide,[4] Madhav joined Metabiota to work on infectious disease modeling and data science. During the ensuing five years, Madhav's team worked on models to predict epidemiological preparedness and readiness of economies to absorb losses experienced in these extreme, "Black swan theory" events.[5] These models were formalized into the Epidemic Preparedness Index.[6]

Along with colleagues from Stanford and Metabiota, Madhav co-authored a chapter on pandemic preparedness for the World Bank.[7]

She was promoted to CEO in 2019.[8]

In 2020, Madhav remarked that Metabiota's AI-powered models were capable of forecasting epidemics based on both formal and informal data sources.[9]

References

  1. ^ "Team | Metabiota". metabiota.com. Retrieved 2020-06-29.
  2. ^ Bakshi, Akanksha (19 August 2022). "Cathie Wood Favorite Ginkgo Bioworks Bolsters Biosecurity Platform Via This Acquisition". Yahoo News. Retrieved 28 February 2023.
  3. ^ "Nita Madhav | DCP3". dcp-3.org. Retrieved 2020-06-29.
  4. ^ "We Can Protect the Economy From Pandemics. Why Didn't We?". Wired. ISSN 1059-1028. Retrieved 2020-06-29.
  5. ^ "Using Modern Data and Analytics To Confront the Challenge of Epidemic Risk". BRINK – News and Insights on Global Risk. Retrieved 2020-06-29.
  6. ^ Oppenheim, Ben; Gallivan, Mark; Madhav, Nita K.; Brown, Naor; Serhiyenko, Volodymyr; Wolfe, Nathan D.; Ayscue, Patrick (2019-01-01). "Assessing global preparedness for the next pandemic: development and application of an Epidemic Preparedness Index". BMJ Global Health. 4 (1): e001157. doi:10.1136/bmjgh-2018-001157. ISSN 2059-7908. PMC 6352812. PMID 30775006.
  7. ^ Madhav, Nita; Oppenheim, Ben; Gallivan, Mark; Mulembakani, Prime; Rubin, Edward; Wolfe, Nathan (2017), Jamison, Dean T.; Gelband, Hellen; Horton, Susan; Jha, Prabhat (eds.), "Pandemics: Risks, Impacts, and Mitigation", Disease Control Priorities: Improving Health and Reducing Poverty (3rd ed.), Washington (DC): The International Bank for Reconstruction and Development / The World Bank, doi:10.1596/978-1-4648-0527-1_ch17, ISBN 978-1-4648-0527-1, PMID 30212163, retrieved 2020-06-29
  8. ^ GmbH, finanzen net. "Metabiota Appoints Distinguished Data Scientist and Disease Modeler as CEO | Markets Insider". markets.businessinsider.com. Retrieved 2020-06-29.
  9. ^ "Data predicted coronavirus and where it may spread next". Marketplace. 2020-02-05. Retrieved 2020-06-29.